Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 13 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
DOCORA from Antwerpen, company number BE0825881259, closed financial year 2025 with a result of € 2.3 million after tax. For that financial year DOCORA recorded a gross margin of € 7.8 million and equity of € 53.6 million. Compared with financial year 2024, the result moved from € 1.5 million to € 2.3 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 17, 2026.
€ 53.6 million
▲ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2.3 million
▲ 49% vs 2024
Profit after tax over the fiscal year.
€ 2,148
▲ 25% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 3.8 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 184,111
▼ 47% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 952,926
▲ 40% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 5,922,030 | € 7,249,128 | € 7,445,310 | € 7,821,772 | ▲ 5% |
| Profit after taxes | € 640,137 | € 526,222 | € 1,529,567 | € 2,284,502 | ▲ 49% |
| Equity | € 49,271,645 | € 49,797,867 | € 51,327,434 | € 53,611,936 | ▲ 4% |
| Total debts | € 29,687,555 | € 31,301,871 | € 18,118,888 | € 9,488,758 | ▼ 48% |
| Cash | € 1,017 | € 59,906 | € 1,723 | € 2,148 | ▲ 25% |
| Land & buildings | € 9,353,305 | € 9,041,555 | € 8,729,806 | € 8,418,056 | ▼ 4% |
| Retained profit | € -515,355 | € 10,867 | € 1,540,434 | € 3,824,936 | ▲ 148% |
| Balance sheet total | € 78,959,200 | € 81,099,737 | € 69,446,322 | € 63,100,694 | ▼ 9% |
Key figures of DOCORA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to DOCORA?
What happened at DOCORA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Opus Terrae BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.3 million (▲ 49% vs 2024). filed late Source: NBB ↗
- Ghemic BV became a director. NBB
- Opus Terrae BV became a director. NBB
- New establishment in Ieper. KBO
- Start of the company according to the CBE. KBO
In short
From € 640,137 profit in 2022 to € 2.3 million profit in 2025.
Paid € 1.2 million in corporate taxes since 2022.
Best year ever: 2025, with € 2.3 million profit.
A new publication or filing at DOCORA? We notify you, reason included.
Follow DOCORADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of GHELAMCO INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
DOCORABehind DOCORA is Ghemic BV. The shares are held by GHELAMCO INVEST (100%).
Directors
According to the 2025 annual accounts
Director · represented by Michael Gheysens
Also active at: GHELAMCO INVEST, SOGIMES, THE WHITE HOUSE ZOUTE, STEELCON, IMMOBILIERE COGIMES, MeetDistrict, VERBENA, CMI +4 more
since 2025
Managing director · represented by Paul Gheysens
Also active at: DOCK-SITE, R.H.R. - INDUSTRIES, GHELAMCO INVEST, THE WHITE HOUSE ZOUTE, SAFE HOLDING BELGIUM, Zeewind, MeetDistrict, PGP +15 more
since 2025 · until 2029
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Oude Bosuilbaan 54 box A
2100 Antwerpen
Zwaanhofweg 10
8900 Ieper
Active since 12 May 2010
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0825.881.259
- VAT number
- BE 0825.881.259
- Registered office
- Oude Bosuilbaan 54 bus A, 2100 Antwerpen
- Names & denominations
- DOCORA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 12 May 2010
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Verhuur en exploitatie van sociale woningen